Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

tau Antikörper (pTyr18)

Es gibt 1 Publikation für dieses Produkt. Der Maus Monoklonal anti-tau Antikörper wird verwendet zum Nachweis von tau in Proben von Human, Maus und Ratte. Er wurde validiert für WB, IHC und IF.
Produktnummer ABIN2443721
784,10 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 25 bis 32 Werktagen

Kurzübersicht für tau Antikörper (pTyr18) (ABIN2443721)

Target

Alle tau Antikörper anzeigen
tau (tau Protein)

Reaktivität

  • 652
  • 612
  • 602
  • 39
  • 29
  • 27
  • 18
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 751
  • 40
  • 3
  • 2
Maus

Klonalität

  • 628
  • 166
  • 2
Monoklonal

Konjugat

  • 236
  • 47
  • 31
  • 28
  • 24
  • 24
  • 24
  • 24
  • 24
  • 24
  • 24
  • 24
  • 24
  • 23
  • 23
  • 23
  • 23
  • 23
  • 23
  • 22
  • 22
  • 12
  • 11
  • 11
  • 4
  • 4
  • 4
  • 4
  • 4
  • 1
  • 1
Dieser tau Antikörper ist unkonjugiert

Applikation

  • 654
  • 272
  • 263
  • 213
  • 155
  • 127
  • 96
  • 90
  • 85
  • 60
  • 35
  • 32
  • 12
  • 12
  • 12
  • 9
  • 3
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Klon

9G3
  • Bindungsspezifität

    • 47
    • 35
    • 34
    • 33
    • 31
    • 31
    • 30
    • 29
    • 27
    • 26
    • 25
    • 25
    • 23
    • 23
    • 23
    • 22
    • 22
    • 17
    • 17
    • 17
    • 17
    • 16
    • 16
    • 16
    • 15
    • 15
    • 10
    • 10
    • 10
    • 8
    • 6
    • 5
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    AA 12-24, pTyr18

    Verwendungszweck

    Phospho-Tau (tyr 18) Mouse Monoclonal Antibody (9G3)

    Spezifität

    The antibody recognizes the human Phospho-Tau protein at the tyrosine 18 phosphorylation site with no detectable cross-reactivity.

    Aufreinigung

    Protein G purified

    Immunogen

    Peptide

    Isotyp

    IgG2a
  • Applikationshinweise

    WB 1:1000-1:5000,IHC 1:1000-1:5000,IF 1:2000-1:5000

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    If reconstituted with deionized water in 100 μL: WB 1:1000-1:5000, IHC 1:1000-1:5000, IF 1:2000-1:5000. Optimal dilution has to be determined by the user.

    Buffer

    Lyophilized protein G purified in PBS pH 7.4

    Konservierungsmittel

    Without preservative

    Lagerung

    4 °C,-20 °C,-80 °C

    Informationen zur Lagerung

    Lyophilized antibodies can be kept at 4°C for up to 3 months and should be kept at -20°C for long-term storage (2 years). To avoid freeze-thaw cycles, reconstituted antibodies should be aliquoted before freezing for long-term (1 year) storage (-80°C) or kept at 4°C for short-term usage (2 months). For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made with the assay buffer. After the maximum long-term storage period (2 years lyophilized or 1 year reconstituted) antibodies should be tested in your assay with a standard sample to verify if you have noticed any decrease in their efficacy. To limit antibody loss or degradation, BSA (final concentration 1%) and sodium azide (final concentration 0.02%) can be added to the suggested first dilution. It is important to first verify if those preservatives are compatible with your assay.

    Haltbarkeit

    24 months
  • Tang, Fesharaki-Zadeh, Takahashi, Nies, Smith, Luo, Chyung, Chiasseu, Strittmatter: "Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy." in: Acta neuropathologica communications, Vol. 8, Issue 1, pp. 96, (2020) (PubMed).

  • Target

    tau (tau Protein)

    Andere Bezeichnung

    tau

    Hintergrund

    Phosphorylated Tau

    Tauopathies are a group of diverse dementias and movement disorders which have a common pathological feature in that they all display the presence of intracellular accumulation of abnormal filaments of Tau protein. While the abnormal phosphorylation of Tau on serine and threonine has been well established in the disease process, its phosphorylation on tyrosine 18 has only recently been described as present in Alzheimer's disease (AD) brain.

    UniProt

    P10636
Sie sind hier:
Chat with us!